FDA misbranding violations for food and supplements cover any product whose label is false, misleading, missing required information, or presented in a way that leaves an ordinary consumer with the wrong impression. The Federal Food, Drug, and Cosmetic Act sets the standard, and it is strict: a product can be legally misbranded even when the manufacturer had no intent to deceive. Consequences range from a public warning letter to product seizure, mandatory recall, and criminal prosecution carrying fines up to $250,000 for individuals and prison time up to three years.
What Makes a Label Misbranded
Misbranding falls into two broad categories. The first is a label that omits something federal law requires. The second is a label that says or implies something false or misleading. Either one is enough on its own.
Under 21 U.S.C. § 343, every food and supplement label must carry a statement of identity (the common name of the product), an accurate statement of net quantity, and the name and place of business of the manufacturer, packer, or distributor.1Office of the Law Revision Counsel. 21 USC 343 – Misbranded Food Food products need a Nutrition Facts panel; dietary supplements need a Supplement Facts panel.2eCFR. 21 CFR 101.9 – Nutrition Labeling of Food Skip any one of these and the product is misbranded by default.
Placement matters as much as content. The principal display panel (the part shoppers see first) must carry the product’s identity and net contents. Ingredient lists and nutrition data go on the information panel, typically to the right.3eCFR. 21 CFR Part 101 – Food Labeling Required information also has to be prominent enough that an ordinary consumer would notice and understand it in normal shopping conditions.1Office of the Law Revision Counsel. 21 USC 343 – Misbranded Food Correct information buried in unreadable type on the wrong panel still counts as a violation.
The false-or-misleading standard is deliberately broad. A label is misbranded if it is “false or misleading in any particular,” and that phrase covers text, images, vignettes, brand names, and the overall impression the packaging creates.4Office of the Law Revision Counsel. 21 USC 343 – Misbranded Food A juice box showing fresh blueberries on the front, when the drink contains only artificial flavoring, is misleading even if no written claim mentions real fruit. A brand name suggesting a specific geographic origin or artisanal production, when neither is true, has the same effect. So does the word “natural” on a product containing synthetic preservatives. The FDA judges labels from the perspective of an ordinary consumer without specialized knowledge, so clever wording and fine print will not rescue a headline that leaves the wrong impression.
The Line Between a Supplement and an Unapproved Drug
The fastest way for a supplement label to become a federal problem is a disease claim. Dietary supplements are allowed to make structure/function claims, which describe how a nutrient affects the body’s normal functioning. “Calcium builds strong bones” is the classic example.5U.S. Food and Drug Administration. Structure/Function Claims Structure/function claims must be truthful and non-misleading, and the label has to carry a specific disclaimer in boldface type: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”6U.S. Food and Drug Administration. Notifications for Structure/Function and Related Claims in Dietary Supplement Labeling
The moment a label claims or implies the supplement can treat, cure, or prevent a specific disease (cancer, diabetes, Alzheimer’s, heart disease, and so on), the product is legally reclassified as an unapproved new drug.7U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements That reclassification triggers the full weight of drug-approval requirements and opens the door to criminal prosecution.
A narrower middle category exists: qualified health claims. These describe an emerging relationship between a substance and reduced disease risk when the evidence is not strong enough to meet the FDA’s “significant scientific agreement” standard. The FDA reviews the evidence and, if it finds the science credible, issues a letter of enforcement discretion permitting the claim with specific qualifying language that flags the limits of the evidence.8U.S. Food and Drug Administration. Label Claims for Conventional Foods and Dietary Supplements Using such a claim without the qualifying language, or without having gone through the petition process, is misbranding.
When Silence Is a Violation
Misbranding does not require an affirmative lie. Under 21 U.S.C. § 321(n), a label is misleading if it fails to reveal facts that are material given the claims it makes or the consequences of using the product.9Office of the Law Revision Counsel. 21 USC Chapter 9 – Federal Food, Drug, and Cosmetic Act – Section: Definitions Advertising a health benefit while omitting known safety drawbacks or interactions is treated as seriously as a false statement.
The highest-stakes omission involves food allergens. The Food Allergen Labeling and Consumer Protection Act (FALCPA) identifies eight major allergens (milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, and soybeans), and the FASTER Act of 2021 added sesame as the ninth. If a product contains any of these, the label must either name the allergen’s food source in parentheses inside the ingredient list or include a separate “Contains” statement immediately after the ingredients.10U.S. Food and Drug Administration. Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA) A missing allergen disclosure creates a direct safety hazard, and it is the one category of misbranding that can trigger a mandatory recall.
How the FDA Enforces Misbranding
Enforcement usually escalates in stages. Most cases start with the least aggressive tool and move up only if the company does not cooperate.
Warning Letters
The first formal step is typically a warning letter identifying the specific violations and requesting a written corrective action plan within 15 working days.11U.S. Food and Drug Administration. Regulatory Procedures Manual – Section: Warning Letter Format Warning letters are public. They appear on the FDA’s website, where customers, competitors, and investors can read them. Companies that respond quickly with genuine corrections often close the matter here. Ignoring the letter almost guarantees escalation.
Seizures and Injunctions
If voluntary compliance fails, the FDA can ask a federal court to seize the misbranded products. The action is technically filed against the goods themselves, and federal marshals or other authorized officers take physical custody.12Legal Information Institute. Federal Rules of Civil Procedure Rule G – Forfeiture Actions in Rem Seized inventory is often destroyed, so the financial hit goes well beyond legal fees. The government can also seek a permanent injunction ordering the company to stop distributing misbranded products, which can shut down a product line, or in extreme cases an entire operation, until the company proves compliance to the court’s satisfaction.
Mandatory Recalls
For allergen-related misbranding, the FDA has authority under 21 U.S.C. § 350l (added by the Food Safety Modernization Act) to order a mandatory recall. Two conditions must be met: a reasonable probability that the food is misbranded under section 403(w), the allergen labeling provision, and a reasonable probability that exposure will cause serious adverse health consequences or death.13U.S. Food and Drug Administration. Questions and Answers Regarding Mandatory Food Recalls: Guidance for Industry and FDA Staff The agency must first offer the company a chance to recall voluntarily. Only if the company refuses can the Commissioner compel one. Most recalls end up voluntary, but the mandatory authority gives the FDA real leverage when a company tries to stonewall.
Criminal Penalties and Fines
Misbranding is not only a regulatory matter. It can be a federal crime, and the penalties fall into two tiers.
- Misdemeanor (first offense, no intent to defraud): up to one year in prison. Section 333 lists a $1,000 statutory fine, but the general federal sentencing statute raises the effective maximum to $100,000 for individuals and $200,000 for organizations.14Office of the Law Revision Counsel. 21 USC 333 – Penalties15Office of the Law Revision Counsel. 18 USC 3571 – Sentence of Fine
- Felony (intent to defraud or mislead, or a second offense): up to three years in prison. The same general sentencing statute raises the effective fine ceiling to $250,000 for individuals and $500,000 for organizations.14Office of the Law Revision Counsel. 21 USC 333 – Penalties15Office of the Law Revision Counsel. 18 USC 3571 – Sentence of Fine
The intent-to-defraud element decides which tier applies. A first-time offender who did not know about an allergen labeling requirement faces misdemeanor exposure. A company that deliberately uses misleading imagery or invents health claims faces felony charges from the start, with no prior conviction required. Courts can also impose fines calculated as twice the gross gain from the violation or twice the gross loss to consumers, whichever is greater, which can dwarf the statutory ceilings for large operations.15Office of the Law Revision Counsel. 18 USC 3571 – Sentence of Fine
Formal sentencing is often not the worst of it. A public enforcement action brings retailer delisting, loss of import privileges, reputational damage that takes years to repair, and heightened FDA scrutiny on every future product. For supplement companies, where consumer trust is the entire business model, that combination can end the company.
Small Business Exemptions and What They Do Not Cover
Two FDA exemptions reduce the Nutrition Facts labeling burden for qualifying small operations:
- Low-volume product exemption: a company with fewer than 100 full-time equivalent employees that sells fewer than 100,000 units of a particular product in the United States per year can skip the Nutrition Facts panel for that product. The business must file an annual notice with the FDA, and products bearing nutrition claims do not qualify.
- Small retailer exemption: a retailer with total annual gross sales of $500,000 or less, or whose annual food and supplement sales to consumers total $50,000 or less, is exempt without filing anything.
These exemptions apply only to the Nutrition Facts requirement.16U.S. Food and Drug Administration. Small Business Nutrition Labeling Exemption Every other labeling rule still applies: statement of identity, net contents, ingredient lists, allergen declarations, and the false-or-misleading standard. Qualifying for the exemption is not a general free pass on misbranding.